<--- Back to Details
First PageDocument Content
Amides / Dipeptidyl peptidase-4 inhibitors / Bristol-Myers Squibb / Nitriles / Metformin / Dapagliflozin / Anti-diabetic medication / Saxagliptin / Sulfonylurea / Chemistry / Organic chemistry / Anti-diabetic drugs
Date: 2015-04-22 23:39:46
Amides
Dipeptidyl peptidase-4 inhibitors
Bristol-Myers Squibb
Nitriles
Metformin
Dapagliflozin
Anti-diabetic medication
Saxagliptin
Sulfonylurea
Chemistry
Organic chemistry
Anti-diabetic drugs

Add to Reading List

Source URL: www.pbs.gov.au

Download Document from Source Website

File Size: 123,79 KB

Share Document on Facebook

Similar Documents

Anatomy / Diabetic nephropathy / Chronic kidney disease / Insulin / Dapagliflozin / Anti-diabetic medication / Diabetes / Medicine / Endocrine system

Att vara eller inte vara .... trender inom läkemedelsforskning Anders Ekblom Mölndal 2 December 2013

DocID: 1gs0F - View Document

Forxiga, INN-dapagliflozin

DocID: 1eAhO - View Document

Medicine / Organochlorides / Sulfonylureas / Diabetes / Guanidines / Metformin / Dapagliflozin / Sitagliptin / Glibenclamide / Chemistry / Organic chemistry / Anti-diabetic drugs

5.4 EMPAGLIFLOZIN, oral tablet, 10 mg, 25 mg, Jardiance®, Boehringer Ingelheim Pty Ltd Purpose of Application This submission seeks an Authority required listing for empagliflozin (Jardiance®) for the treatment of typ

DocID: 17Ihe - View Document

Health / Metformin / Sulfonylurea / Dapagliflozin / Diabetes mellitus type 2 / Diabetes mellitus / Glycated hemoglobin / Diabetes / Endocrine system / Medicine

6.3 DAPAGLIFLOZIN, 10 mg tablet, Forxiga®, AstraZeneca Pty Ltd 1 Purpose of Application To request amendments to the current restriction for dapagliflozin for use in diabetes mellitus type 2 (T2DM) to provide prescribe

DocID: 17FDZ - View Document

Immunosuppressants / Rituximab / Certolizumab pegol / Scottish Medicines Consortium / Botulinum toxin / Multiple myeloma / Lenalidomide / Dapagliflozin / Alternative medicine / Medicine / Pharmacology / Chemistry

Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

DocID: 177rO - View Document